All Updates

Yesterday, both chambers in the New Jersey State Legislature passed legislation (Assembly Bill 4163 / Senate Bill 3098) to increase access to biomarker testing, which can help determine the best treatment plan for each patient. The bill will now go to Governor Murphy’s desk, providing him the opportunity to ensure coverage of this essential testing for more New Jerseyans. The American Cancer Society Cancer Action Network (ACS CAN) is leading the efforts on this significant policy change to ensure more patients can get the testing needed to access precision medicine.

Des Moines, Iowa – “Iowa has the 2 nd highest cancer rates in the country and our cancer rates continue to rise year over year. The State Legislature’s votes to cut Medicaid expansion will plunge our state deeper into this cancer crisis. Iowa Medicaid serves as a lifeline for many

BISMARCK, N.D. – The North Dakota Senate on Monday passed House Bill 1216 on a 30-14 vote, setting aside a “Do Not Pass” by the Senate Human Services Committee and sending the bill back to Senate Appropriations for review and approval of amendments. The original bill passed the house on

The American Cancer Society Cancer Action Network (ACS CAN) united cancer survivors, patients and caregivers from across Nevada at the state capitol for ‘Cancer Action Day,’ Monday to urge lawmakers to oppose AB76, which is currently being considered by the state legislature. If enacted, the bill would allow for indoor cannabis smoking and weaken the Nevada Clean Indoor Air Act.

HELENA, Mont. –– Cancer patients, survivors, caregivers and advocates from throughout the state called on lawmakers Monday to honor the Montana Clean Indoor Air Act and kill Senate Bill 150, which would allow cigar smoking in restaurants, bars and gaming facilities that are currently smoke-free. State polling shows that 89%

BISMARCK, N.D. –– House Bill 1283 was given a 4-1 Do Not Pass by the North Dakota Senate Business and Industry Committee on Monday following passage in the House. The bill would put North Dakotans one step closer to the peace of mind they need when it comes to breast

Un nuevo informe (en inglés) de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) reveló que más del 70% de las pacientes con seguro médico comercial tuvieron gastos de bolsillo para pruebas de diagnóstico de seguimiento para el cáncer de mama en 2023.

Un nuevo informe (en inglés) de la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) reveló que más del 70% de las pacientes con seguro médico comercial tuvieron gastos de bolsillo para pruebas de diagnóstico de seguimiento para el cáncer de mama en 2023.

Como uno de los principales grupos de defensa de los pacientes que avanzó la aprobación de la Ley de Protección al Paciente y Cuidado de Salud a Bajo Precio (ACA), la Red de Acción Contra el Cáncer de la Sociedad Americana Contra el Cáncer (ACS CAN) celebra el domingo el 15º aniversario de esta histórica ley, destacando sus efectos positivos y pidiendo a los legisladores que la protejan.